Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-20-064584

Chief Commercial Officer sold 25,000 shares at $0.73 ($18,250)

From the SEC's structured data for this filing

Trades in this filing

Maloberti Renaud Bertrand · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-12-17 Sale : show line 1 in the form −25,000 $0.73 $18,250 41,580 D
Open-market sales · 25,000 sh · avg $0.73 · $18,250
Loading xslF345X03/doc4.xml…